Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Emily Van Wagoner"'
Autor:
Richard Sawyer, Emily Van Wagoner, Romina Benitez, W. Cully Hession, Emily Garner, Amy Pruden, Leigh-Anne Krometis, Erin Schaberg, Brian D. Badgley
Publikováno v:
Water Research. 123:144-152
Antibiotic resistance presents a critical public health challenge and the transmission of antibiotic resistance via environmental pathways continues to gain attention. Factors driving the spread of antibiotic resistance genes (ARGs) in surface water
Publikováno v:
Journal of Environmental Management. 198:348-352
Pharmaceutical pollution in surface waters poses a range of risks to public health and aquatic ecosystems. Consumers contribute to pharmaceutical pollution via use and disposal of medications, though data on such behaviors is limited. This paper inve
Autor:
Erin Schaberg, Richard Sawyer, Emily Van Wagoner, Romina Benitez, Leigh-Anne Krometis, W. Cully Hession, Hehuan Liao, Brian D. Badgley
Publikováno v:
Science of The Total Environment. :347-356
Elevated concentrations of fecal indicator bacteria in receiving waters during wet-weather flows are a considerable public health concern that is likely to be exacerbated by future climate change and urbanization. Knowledge of factors driving the fat
Autor:
Amy Pruden, Emily Garner, Garner Badgley, Joshua Wallace, Mazdak Arabi, Cully Hession, Richard Sawyer, Emily Van Wagoner, Romina Benitez, Leigh-Anne Krometis, Diana S. Aga
Publikováno v:
Proceedings of the Water Environment Federation. 2014:1783-1794
Autor:
Tia-Marie Scott, Christine Vatovec, Patrick J. Phillips, Emily Van Wagoner, Edward T. Furlong
Publikováno v:
The Science of the total environment. 572
Pharmaceutical pollution in surface waters poses risks to human and ecosystem health. Wastewater treatment facilities are primary sources of pharmaceutical pollutants, but little is known about the factors that affect drugs entering the wastewater st
Autor:
Brian J. Bolwell, Chad W. Cummings, Katherine Glass, Vamsidhar Velcheti, Nathan A. Pennell, James P. Stevenson, Marc A. Shapiro, Emily Van Wagoner, Alicia M Redden
Publikováno v:
Journal of Clinical Oncology. 34:29-29
29 Background: Patient-centered outcomes are important quality metrics of value-based cancer care. For NSCLC, these include chemotherapy administration within 30 days of death and end of life hospitalizations. Nivolumab was initially FDA approved in
Autor:
James P. Stevenson, Patrick C. Ma, Katherine Glass, Abdo Haddad, Bruno R. Bastos, Vamsidhar Velcheti, Chad W. Cummings, Emily Van Wagoner, Marc A. Shapiro, Brian J. Bolwell, Nathan A. Pennell
Publikováno v:
Journal of Clinical Oncology. 33:6609-6609
6609 Background: Care pathways can reduce cancer care costs and variability in NSCLC. Effective implementation requires measurable outcomes and available data in near real-time. Methods: Between 10...